InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Patel Sujal M, Chairman & CEO. Insider active across 1 companies, notably Nautilus Biotechnology, Inc.. In total, 4 filings have been published. Total volume traded: €1.7m. The latest transaction was filed on 9 May 2022 — Acquisition. Regulator: SEC (Form 4). The full history is free.
Declarations4 total
€187,39750,000 shares@ €3.74790.076% mcap11.0% of flow
Common Stock
SEC:0001808805-22-000054:0·
Ideal exit: 3 Feb 2023 (T+270)
€161,88350,000 shares@ €3.23770.066% mcap9.5% of flow
Common Stock
SEC:0001808805-22-000026:0·
Ideal exit: 28 Nov 2022 (T+270)
€677,189161,978 shares@ €4.1807100.0% of flow
Common Stock
SEC:0001808805-21-000027·
Ideal exit: 27 Aug 2022 (T+270)
€677,189161,978 shares@ €4.18070.27% mcap39.7% of flow
Common Stock
SEC:0001808805-21-000027:0·
Ideal exit: 27 Aug 2022 (T+270)
4 of 4 declarations
About Patel Sujal M
Sujal M. Patel is the Chief Executive Officer, President, and Secretary of Nautilus Biotechnology, Inc. He leads the company with a strategic vision, focusing on innovation and growth. His leadership is crucial in guiding the company's initiatives in the biotechnology sector.
